APH1A Gene

📖 Wiki Page

gene874 wordssynced 2026-04-02

APH1A Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">APH1A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>APH1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>APH1A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=APH1" target="_blank">Search NCBI</a></td>
</tr>
</table>

Aph1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

:: infobox .infobox-gene [@sannerud2016] Symbol: APH1A [@serneels2005] Full Name: Anterior Pharynx Defective 1 Homolog A [@acx2014] Chromosomal Location: 1p36.33-p36.32 [@wolfe2017] NCBI Gene ID: [116511](https://www.ncbi.nlm.nih.gov/gene/116511) [@haass2012] OMIM: [607630](https://www.omim.org/entry/607630) [@pettersen2015] Ensembl ID: [ENSG00000144024](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000144024) [@takeo2016] UniProt: [Q9WFF5](https://www.uniprot.org/uniprot/Q9WFF5) Proteins: [APH1A](/proteins/aph1a) Associated Diseases: [Alzheimer's Disease](/diseases/alzheimers-disease)
::

Overview

...

APH1A Gene

Introduction

Aph1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

APH1A (Anterior Pharynx Defective 1 Homolog A) encodes a critical component of the [gamma-secretase](/entities/gamma-secretase) complex, one of the most important enzymatic complexes in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis. APH1A is expressed ubiquitously but shows particularly high expression in the brain, especially in regions vulnerable to AD pathology like the [hippocampus](/brain-regions/hippocampus) and cerebral [cortex](/brain-regions/cortex). The gamma-secretase complex, which includes APH1A, presenilin ([PSEN1](/entities/psen1)/PSEN2), nicastrin, and PEN-2, is responsible for the proteolytic cleavage of [amyloid precursor protein](/entities/app-protein) (APP) to generate [amyloid-beta](/proteins/amyloid-beta) (Abeta) peptides. The specific composition of the gamma-secretase complex, determined in part by which APH1 isoform is incorporated, directly influences the Abeta peptide profile produced.

Gamma-Secretase Complex Assembly

Complex Composition

The gamma-secretase complex is a heterotetrameric aspartyl protease:

Presenilin (PSEN1 or PSEN2): The catalytic subunit containing two aspartyl protease active sites

Nicastrin (NCT): Acts as a substrate receptor, recognizing the extracellular domain of APP

PEN-2 (PSENEN): Essential for presenilin endoproteolysis and stabilization

APH1A or APH1B: Scaffold protein that organizes the complex in the endoplasmic reticulum

APH1 Isoforms

Mammalian cells express two APH1 genes with multiple isoforms:

APH1A: Two isoforms (APH1A-L, APH1A-S) produced by alternative splicing
APH1B/APH1C: Additional isoforms with tissue-specific expression

The different APH1 isoforms confer distinct properties to gamma-secretase:

Substrate preference differences
Endoplasmic reticulum localization
Assembly kinetics
Aβ product profiles (Aβ40 vs Aβ42 ratio)

Molecular Function

Catalytic Activity

Gamma-secretase performs regulated intramembrane proteolysis (RIP):

First cleavage (ε-site): Initial APP cleavage within the transmembrane domain

Second cleavage (γ-site): Successive cleavages releasing Aβ peptides of varying lengths

The Aβ40/Aβ42 ratio produced depends on gamma-secretase composition:

APH1A-containing complexes tend to produce more Aβ40
Certain PSEN1 mutations shift toward Aβ42 production

Substrate Diversity

Gamma-secretase cleaves over 100 type I transmembrane substrates:

Amyloid Precursor Protein (APP)
Notch receptors
E-cadherin
N-cadherin
LDL receptor-related proteins
ErbB4
DCC

This broad substrate range explains the complex biology and side effects of gamma-secretase inhibitors.

Expression Pattern

Brain Expression

[Neurons](/entities/neurons): High expression in pyramidal neurons of cortex and hippocampus
Glia: Moderate expression in [astrocytes](/entities/astrocytes)
Regional variation: Highest in [entorhinal cortex](/brain-regions/entorhinal-cortex), CA1 hippocampus, basal forebrain

Peripheral Expression

Heart, liver, kidney, lung
Lymphocytes
Pancreatic islets

Disease Associations

Alzheimer's Disease

APH1A is centrally involved in AD pathogenesis:

Amyloid-beta production: APH1A-containing gamma-secretase generates Aβ from APP

Genetic variants: Certain APH1A polymorphisms may influence AD risk

Presenilin partnerships: APH1A coordinates with PSEN1/PSEN2 mutations

Therapeutic target: Modulating APH1A-gamma-secretase to reduce toxic Aβ42

Alzheimer's Disease Therapeutics

Gamma-secretase modulators (GSMs): Compounds that shift cleavage toward shorter, less aggregation-prone Aβ peptides

APH1A-targeted approaches: Developing drugs that selectively inhibit APP cleavage while sparing Notch

Allosteric modulators: Targeting APH1A-NCT interface to allosterically modulate activity

Side Effect Considerations

Because gamma-secretase also cleaves Notch:

Complete inhibition causes gastrointestinal toxicity
Partial inhibition or modulation preferred over complete blockade
APH1 isoform-selective modulation is an active research area

Therapeutic Implications

Drug Development Strategies

Selective GSMs: Preferentially promote non-amyloidogenic APP processing

Notch-sparing inhibitors: Target APP cleavage while preserving Notch signaling

Antibody-based approaches: Target APH1A or gamma-secretase complex assembly

Challenges

Broad substrate specificity of gamma-secretase
Mechanism-based toxicity from Notch inhibition
Need for brain-penetrant compounds
[Gamma-Secretase Complex](/proteins/gamma-secretase)
[APP Processing](/mechanisms/app-processing)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[APH1A Protein](/proteins/aph1a)
[Gene index](/genes)
[--](/proteins/n--cadherin-protein)

Background

The study of Aph1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[De Strooper B, "Loss-of-function presenilin mutations in Alzheimer disease." EMBO Journal (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29251994/)

[Sannerud R, Esselens C, Ejsmont P, et al, "Restricted location of PSEN2/γ-secretase determines substrate specificity and cellular effects of γ-secretase modulators." EMBO Journal (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27294251/)

[Serneels L, Dejaegere T, Craessaerts K, et al, "Differential contribution of the three presenilin genes to the γ-secretase complex in vivo." Proceedings of the National Academy of Sciences (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15677324/)

[Acx H, Chávez-Gutiérrez L, Serneels L, et al, "Signature amyloid β profiles are produced by different γ-secretase complexes." Journal of Biological Chemistry (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24895120/)

[Wolfe MS, " γ-Secretase inhibition and modulation for Alzheimer's disease." Current Alzheimer Research (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28093938/)

[Haass C, Kaether C, Thinakaran G, et al, "Trafficking and proteolytic processing of APP." Cold Spring Harbor Perspectives in Medicine (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22553493/)

[Pettersen M, Iyer G, Srivastava A, et al, "APH1B and APH1C polymorphisms and Alzheimer disease risk." Neurobiology of Aging (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25697672/)

[Takeo K, Tanimura S, Allin O, et al, "ATP1A3 mutations cause focal epilepsy." Brain (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26962052/)

Pathway Diagram

The following diagram shows the key molecular relationships involving APH1A Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →